|
2. Cannabinoids and hormone receptor-positive breast cancer treatmentLuka Dobovišek, Fran Krstanović, Simona Borštnar, Nataša Debeljak, 2020, review article Keywords: hormone receptor, breast cancer, cannabinoids, treatment, CBD, THC, estrogen, cannabinoid receptor
Full text (file, 1,53 MB) This document has more files! More... |
3. Six-minute walk distance in breast cancer survivorsJasna But-Hadžić, Mirza Dervišević, Damir Karpljuk, Mateja Videmšek, Edvin Dervišević, Armin Paravlić, Vedran Hadžić, Katja Tomažin, 2021, review article Keywords: sport, female, cardio-respiratory fitness, reference values, breast cancer, six minute walk test
Full text (file, 1,80 MB) This document has more files! More... |
4. Dual effect of combined metformin and 2-deoxy-D-glucose treatment on mitochondrial biogenesis and PD-L1 expression in triple-negative breast cancer cellsJernej Repas, Mateja Zupin, Maja Vodlan, Peter Veranič, Boris Gole, Uroš Potočnik, Mojca Pavlin, 2022, original scientific article Keywords: protein N-glycosylation, ER stress, AMPK, PD-1/PD-L1 axis, anchorage-independence, metformin, 2-deoxy-D-glucose, triple-negative breast cancer, T cells, mitochondrial biogenesis, triple negative breast neoplasms, T-lymphocytes, deoxyglucose, organelle biogenesis
Full text (file, 5,36 MB) This document has more files! More... |
5. Complete response in the axilla and the non-triple negative subtype are favourable prognostic factors for survival outcomes in inflammatory breast cancerCvetka Grašič-Kuhar, Simona Borštnar, Barbara Gazić, Erika Matos, 2023, original scientific article Keywords: inflammatory breast cancer, immunohistochemistry-based subtype, pathologic complete response, prognostic factors
Full text (file, 2,77 MB) This document has more files! More... |
6. Cytotoxic effect of 13α-estrane derivatives on breast, endometrial and ovarian cancer cell linesAlja Zottel, Rebeka Jójárt, Henrietta Ágoston, Eva Hafner, Neža Lipušček, Erzsébet Mernyák, Tea Lanišnik-Rižner, 2023, original scientific article Keywords: breast cancer, endometrial cancer, ovarian cancer, estrane derivatives, cytotoxicity
Full text (file, 719,32 KB) This document has more files! More... |
|
8. Absence of post-treatment changes in sentinel lymph nodes does not translate into increased regional recurrence rate in initially node-positive breast cancer patientsNina Pišlar, Gorana Gašljević, Ivica Ratoša, Anja Kovač, Janez Žgajnar, Andraž Perhavec, 2023, original scientific article Keywords: breast cancer, neoadjuvant, post-treatment changes, sentinel lymph node biopsy, regional recurrence
Full text (file, 627,51 KB) This document has more files! More... |
9. Breast cancer risk prediction using Tyrer-Cuzick algorithm with an 18-SNPs polygenic risk score in a European population with below-average breast cancer incidenceTjaša Oblak, Petra Škerl, Benjamin J. Narang, Rok Blagus, Mateja Krajc, Srdjan Novaković, Janez Žgajnar, 2023, original scientific article Keywords: early breast cancer, polygenic risk score, risk prediction, Tyrer Cuzick algorithm
Full text (file, 1,54 MB) This document has more files! More... |
10. Targeting the formation of estrogens for treatment of hormone dependent diseases–current statusTea Lanišnik-Rižner, Andrea Romano, 2023, review article Keywords: intracrinology, endometrial cancer, prostate cancer, estrogens, breast cancer, ovarian cancer, endometriosis
Full text (file, 1,20 MB) This document has more files! More... |
